Cosmos Health Inc. - 8-K Filing
Cosmos Health Inc. reported Q1 2026 revenue of $17.93 million, up 30.7% year-over-year from $13.71 million in Q1 2025. Adjusted EBITDA was near breakeven at ($229,596), as increased revenue offset higher operating expenses driven by strategic investments in growth initiatives. Total liabilities decreased by $4.5 million (9.6%) to $42.54 million and stockholders' equity rose 7.6% to $19.83 million. (Items: 2.02 RESULTS OF OPERATIONS AND FINCIAL CONDITION, 9.01 FINANCIAL STATEMENTS AND EXHIBITS)
Tickers: $COSM